CN112359055A - Plasmid pMMB1 for enterobacter gene editing and construction method and application thereof - Google Patents
Plasmid pMMB1 for enterobacter gene editing and construction method and application thereof Download PDFInfo
- Publication number
- CN112359055A CN112359055A CN202011189157.5A CN202011189157A CN112359055A CN 112359055 A CN112359055 A CN 112359055A CN 202011189157 A CN202011189157 A CN 202011189157A CN 112359055 A CN112359055 A CN 112359055A
- Authority
- CN
- China
- Prior art keywords
- plasmid
- pmmb1
- product
- denaturation
- pcr amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 84
- 238000010362 genome editing Methods 0.000 title claims abstract description 14
- 238000010276 construction Methods 0.000 title claims abstract description 10
- 241000588914 Enterobacter Species 0.000 title description 5
- 239000012634 fragment Substances 0.000 claims abstract description 14
- 239000002773 nucleotide Substances 0.000 claims abstract description 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 6
- 238000012546 transfer Methods 0.000 claims abstract description 6
- 238000010367 cloning Methods 0.000 claims abstract description 4
- 238000012408 PCR amplification Methods 0.000 claims description 33
- 230000003321 amplification Effects 0.000 claims description 28
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 23
- 238000011144 upstream manufacturing Methods 0.000 claims description 23
- 108020004414 DNA Proteins 0.000 claims description 20
- 238000012257 pre-denaturation Methods 0.000 claims description 20
- 230000001419 dependent effect Effects 0.000 claims description 15
- 238000011084 recovery Methods 0.000 claims description 14
- 239000005547 deoxyribonucleotide Substances 0.000 claims description 13
- 125000002637 deoxyribonucleotide group Chemical group 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 10
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 10
- 238000000137 annealing Methods 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000004925 denaturation Methods 0.000 claims description 10
- 230000036425 denaturation Effects 0.000 claims description 10
- 239000012154 double-distilled water Substances 0.000 claims description 10
- 238000001976 enzyme digestion Methods 0.000 claims description 10
- 108091008146 restriction endonucleases Proteins 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 238000012216 screening Methods 0.000 claims description 8
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 7
- 108091060592 XDNA Proteins 0.000 claims description 7
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 7
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 7
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 7
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 7
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 7
- 229930027917 kanamycin Natural products 0.000 claims description 7
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 7
- 229960000318 kanamycin Drugs 0.000 claims description 7
- 229930182823 kanamycin A Natural products 0.000 claims description 7
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 229920002670 Fructan Polymers 0.000 claims description 2
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 claims description 2
- 241000519995 Stachys sylvatica Species 0.000 claims description 2
- 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 claims description 2
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 claims description 2
- 101150087698 alpha gene Proteins 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims description 2
- 230000021615 conjugation Effects 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims description 2
- 101150066555 lacZ gene Proteins 0.000 claims description 2
- 101150025220 sacB gene Proteins 0.000 claims description 2
- 230000007017 scission Effects 0.000 claims description 2
- 241000588921 Enterobacteriaceae Species 0.000 abstract description 9
- 230000009466 transformation Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 34
- 241001490645 Serratia sp. ATCC 39006 Species 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 101150015068 PIGA gene Proteins 0.000 description 12
- 238000001514 detection method Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 description 5
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000003209 gene knockout Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 239000012137 tryptone Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000001082 somatic cell Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001821 nucleic acid purification Methods 0.000 description 2
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 108010072454 CTGCAG-specific type II deoxyribonucleases Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides a plasmid pMMB1, the nucleotide sequence of which is shown in SEQ ID NO. 1. The invention also provides a construction method of the plasmid pMMB 1. The invention also provides application of the plasmid pMMB1 in gene editing. The plasmid provided by the invention has a conjugative transfer site oriT (RP4), and can be transferred into a receptor strain by modes of conjugative transfer, transformation and the like; has Multiple Cloning Sites (MCS) and can insert exogenous fragments conveniently and rapidly. Meanwhile, the plasmid can be transferred into an enterobacteriaceae receptor strain in various ways and used for gene editing of enterobacteriaceae bacteria.
Description
Technical Field
The invention relates to a plasmid pMMB1 for enterobacter gene editing and a construction method and application thereof, belonging to the technical field of biology.
Background
In genetic engineering, plasmids are commonly used genetic vectors for carrying foreign genes and transferring them into host cells. Most of the common genetically engineered plasmids are derived from Escherichia coli. In order to achieve gene editing in a host cell, it is necessary to provide screening conditions outside to integrate the plasmid into a specific site on the host chromosome. This requires that the plasmid have the following characteristics: 1. has proper screening marks, and is convenient for screening to obtain recombinant transformants transferred into plasmids; 2. the plasmid is unable to replicate within the host cell, such that external selection pressure forces integration of the plasmid into the host chromosome. 3. The plasmid carries sequences homologous to the host gene and can therefore be integrated into a specific site by homologous recombination.
The origin of replication (oriV) of a genetically engineered plasmid is typically a deoxyribonucleotide sequence that depends on the replication elements of the host cell for plasmid replication. It can be divided into several groups according to its replication mechanism and host type. Since most of the genetically engineered plasmids are derived from Escherichia coli of Enterobacteriaceae, the replication origin thereof can be recognized in cells of various organisms of the Enterobacteriaceae family, so that the plasmids can replicate without integration into the chromosome of the host cell of the Enterobacteriaceae family, and thus gene editing of the host cell cannot be performed.
Disclosure of Invention
The technical problem is as follows: in order to solve the defects of the prior art, the invention aims to construct a genetic engineering plasmid pMMB1 which can be used for enterobacteriaceae gene editing and apply the plasmid to the work of carrying out gene editing on enterobacteriaceae hosts.
The technical scheme is as follows: the invention provides a plasmid pMMB1, the nucleotide sequence of which is shown in SEQ ID NO. 1.
The invention provides a plasmid pMMB1, wherein the nucleotide sequence of the plasmid is a kanamycin resistance gene and a promoter region thereof from the 208-nd 1140-th deoxyribonucleotide at the 5' end; the 1192-position 3053 deoxyribonucleotide is a fructan sucrase gene sacB and a promoter region thereof; 3407-3516 shows that the deoxyribonucleotide is an IncP group plasmid conjugation transfer site; the 4497-4944 deoxyribonucleotide is a lambda pir protein-dependent replicon oriR 6K; 5287-5586-position deoxyribonucleotide is lacZ alpha gene for screening blue white spots and a promoter region thereof; the 5383-5417-site deoxyribonucleotide is a multiple cloning site for inserting an exogenous fragment.
The invention also provides a construction method of the plasmid pMMB1, which comprises the following steps:
(1) preparation of the cleavage product of the lambda pir protein-dependent replicon oriR 6K:
(1.1) carrying out PCR amplification on the lambda pir protein-dependent replicon oriR6K by using the plasmid pKNG101 as a template to obtain an amplification product; recovering the amplification product using a universal nucleic acid recovery kit to obtain a lambda pir protein-dependent replicon oriR 6K;
(1.2) treating the recovered amplification product with restriction endonuclease XhoI to obtain a lambda pir protein-dependent replicon oriR6K enzyme-cleaved product, and recovering the product by using a general-purpose nucleic acid recovery kit;
(2) preparation of plasmid backbone digestion product:
(2.1) PCR-amplifying sequences except the replicon by using an upstream primer DoriF and a downstream primer DoriR with the plasmid pK19mobsacB as a template to obtain an amplification product. Recovering the amplification product by using a universal nucleic acid recovery kit to obtain a plasmid skeleton;
(2.2) treating the recovered amplification product with restriction endonuclease XhoI to obtain a plasmid backbone enzyme digestion product, and recovering the enzyme digestion product by using a universal nucleic acid recovery kit;
(3) preparation of plasmid pMMB 1:
and connecting the lambda pir protein dependent replicon oriR6K enzyme digestion product with the plasmid skeleton enzyme digestion product to obtain the pMMB1 plasmid.
Wherein, in the step (1.1),
the amplification primers in the PCR amplification system are as follows:
the upstream primer R6 KF: 5-CCGCTCGAGTCTGAAGATCAGCAGTTCAACCTG-3;
the downstream primer R6 KR: 5-CCGCTCGAGAGCTTTGTCATCACCAATTTCCTT-3;
the PCR amplification system is 25 μ L, and comprises:
10 XDNA polymerase buffer 2.5. mu.L; 0.2mmol/L dATP; 0.2mmol/L dTTP; 0.2mmol/L dCTP; 0.2mmol/L dGTP; the upstream primer R6KF 0.3 is 0.3 mu mol/L; the downstream primer R6KR 0.3 is 0.3 mu mol/L; 0.1 mu g of template DNA; KOD DNA polymerase 0.5U, magnesium ion 1.5mmol/L, make up the remaining volume with sterilized double distilled water;
the reaction conditions for PCR amplification are as follows:
pre-denaturation at 98 ℃ for 5 min, after the pre-denaturation had ended the following procedure was carried out: denaturation at 98 ℃ for 10 seconds, annealing at 55 ℃ for 30 seconds, extension at 68 ℃ for 20 seconds, repeating for 30 cycles; after the circulation was completed, the temperature was 68 ℃ for 10 minutes.
Wherein, in the step (2.1),
the amplification primers in the PCR amplification system are as follows:
DoriF:5-CCGCTCGAGGAGCCTATGGAAAAACGCCAGCAACGCGGC-3;
DoriR:5-CCGCTCGAGTCTCAAGAAGATCCTTTGATCTTTTCTACG-3;
the PCR amplification system is 25 μ L, and comprises:
10 XDNA polymerase buffer 2.5. mu.L; 0.2mmol/L dATP; 0.2mmol/L dTTP; 0.2mmol/L dCTP; 0.2mmol/L dGTP; upstream primer DoriF 0.3 mu mol/L; downstream primer DoriR 0.3 mu mol/L; 0.1 mu g of template DNA; KOD DNA polymerase 0.5U, magnesium ion 1.5mmol/L, make up the remaining volume with sterilized double distilled water;
the reaction conditions for PCR amplification are as follows:
pre-denaturation at 98 ℃ for 5 min, after the pre-denaturation had ended the following procedure was carried out: denaturation at 98 ℃ for 10 seconds, annealing at 55 ℃ for 30 seconds, extension at 68 ℃ for 3 minutes, and 30 cycles were repeated. After the circulation was completed, the temperature was 68 ℃ for 10 minutes.
The invention also provides application of the plasmid pMMB1 in gene editing.
Has the advantages that: the plasmid provided by the invention has a conjugative transfer site oriT (RP4), and can be transferred into a receptor strain by modes of conjugative transfer, transformation and the like; has Multiple Cloning Sites (MCS) and can insert exogenous fragments conveniently and rapidly. Meanwhile, the plasmid can be transferred into an enterobacteriaceae receptor strain in various ways and used for gene editing of enterobacteriaceae bacteria.
Drawings
FIG. 1 is a physical map of plasmid pMMB 1;
FIG. 2 is a single-crossover detection electrophoretic analysis of the knockdown of the prodigiosin synthesis gene pigA of Serratia sp.ATCC 39006 by using pMMB1 plasmid in example 2 of the present invention;
FIG. 3 is a double crossover detection electrophoretic analysis of the knockdown of the prodigiosin synthesis gene pigA of Serratia sp.ATCC 39006 by using pMMB1 plasmid in example 2 of the present invention;
FIG. 4 is a photograph comparing colonies of the wild-type Serratia sp.ATCC 39006 strain and the pig A deletion mutant strain cultured on LB solid medium at 28 ℃ for 12 hours.
Detailed Description
The following examples are given to further describe the present invention in detail with reference to specific embodiments. The following examples are intended to illustrate the invention, but not to limit the scope of the invention.
The experimental procedures in the following examples are conventional, except for the specific illustrations. The raw materials and test reagents used in the examples were commercially available products except for those specifically mentioned.
In the following examples, the LB plate comprises: 10g/L tryptone; 10g/L of sodium chloride; 5g/L yeast extract; 20g/L agar powder. The LB liquid medium comprises: 10g/L tryptone; 10g/L of sodium chloride; 5g/L yeast extract. The M9 plate comprises: 12.8g/L of Na2HPO4·H2O; KH of 3g/L2PO4(ii) a 0.5g/L NaCl; 1.0g/L NH4Cl; 2mmol/L MgSO40.4g/L glucose, 0.1mmol/L CaCl220g/L agar powder. The LC liquid medium comprises: 10g/L tryptone; 5g/L (w/v) of yeast extract. The LCS plate comprises: 10g/L tryptone; 5g/L yeast extract; 20g/L of sucrose; 20g/L agar powder.
Example 1: construction of the plasmid pMMB1 for Enterobacter Gene editing described in the present invention
PCR amplification was performed using pNKG 101 plasmid as a template and the primer pair R6KF/R6KR to obtain the amplification product lambda pir protein-dependent replicon oriR 6K. And recovering the amplification product by using a universal nucleic acid recovery kit.
Wherein, the amplification primers R6KF and R6KR in the PCR amplification system are respectively:
R6KF:5-CCGCTCGAGTCTGAAGATCAGCAGTTCAACCTG-3
R6KR:5-CCGCTCGAGAGCTTTGTCATCACCAATTTCCTT-3
the PCR amplification system is 25 μ L, and comprises:
10 XDNA polymerase buffer 2.5. mu.L; magnesium ion 1.5 mmol/L; 0.2mmol/L dATP; 0.2mmol/L dTTP; 0.2mmol/L dCTP; 0.2mmol/L dGTP; the upstream primer R6KF 0.3 is 0.3 mu mol/L; the downstream primer R6KR 0.3 is 0.3 mu mol/L; 0.1 mu g of template DNA; KOD high fidelity DNA polymerase 0.5U; the remaining volume was replenished with sterile double distilled water.
The reaction conditions for PCR amplification are as follows:
pre-denaturation at 98 ℃ for 5 min, after the pre-denaturation had ended the following procedure was carried out: denaturation at 98 ℃ for 10 seconds, annealing at 55 ℃ for 30 seconds, and extension at 68 ℃ for 20 seconds, followed by 30 cycles. After the circulation was completed, the temperature was 68 ℃ for 10 minutes.
The recovered amplification product was treated with restriction endonuclease XhoI to obtain a lambda pir protein-dependent replicon oriR6K enzyme-cleaved product, which was recovered using a general-purpose nucleic acid recovery kit.
The DoriF/DoriR was PCR-amplified using the primers using plasmid pK19mobsacB as a template to obtain an amplification product. The amplification product is a sequence other than the pK19mobsacB plasmid replicon. And recovering the amplification product by using a universal nucleic acid recovery kit to obtain the plasmid skeleton.
Wherein, the amplification primers DoriF and DoriR in the PCR amplification system are respectively:
DoriF:5-CCGCTCGAGGAGCCTATGGAAAAACGCCAGCAACGCGGC-3
DoriR:5-CCGCTCGAGTCTCAAGAAGATCCTTTGATCTTTTCTACG-3
the PCR amplification system is 25 μ L, and comprises:
10 XDNA polymerase buffer 2.5. mu.L; magnesium ion 1.5 mmol/L; 0.2mmol/L dATP; 0.2mmol/L dTTP; 0.2mmol/L dCTP; 0.2mmol/L dGTP; upstream primer DoriF 0.3 mu mol/L; downstream primer DoriR 0.3 mu mol/L; 0.1 mu g of template DNA; KOD DNA polymerase 0.5U; the remaining volume was replenished with sterile double distilled water.
The reaction conditions for PCR amplification are as follows:
pre-denaturation at 98 ℃ for 5 min, after the pre-denaturation had ended the following procedure was carried out: denaturation at 98 ℃ for 10 seconds, annealing at 55 ℃ for 30 seconds, extension at 68 ℃ for 3 minutes, and 30 cycles were repeated. After the circulation was completed, the temperature was 68 ℃ for 10 minutes.
And (3) treating the recovered amplification product by using restriction endonuclease XhoI to obtain a plasmid backbone enzyme digestion product, and recovering the plasmid backbone enzyme digestion product by using a universal nucleic acid recovery kit.
And (3) connecting the cut product of the lambda pir protein-dependent replicon oriR6K with the cut product of the plasmid skeleton to obtain the pMMB1 plasmid (shown in the attached figure 1), and after a colony PCR is identified as a positive clone, extracting the plasmid and sequencing to determine the nucleotide sequence (shown in SEQ ID NO. 1).
Example 2: method for constructing gene knockout plasmid by using pMMB1 plasmid
In this example, a method of constructing a gene knockout vector pMMB1-DpigA for knocking out the pigA gene (Ser39006_020695) in Serratia sp.ATCC 39006 by using the pMMB1 plasmid in example 1 is described. The method comprises the following steps:
the pMMB1 plasmid is cut by restriction endonuclease PstI and restriction endonuclease BamHI, and the cut pMMB1 plasmid is recovered by a general nucleic acid purification and recovery kit;
performing PCR amplification on an upstream homology arm and a downstream homology arm of a pigA gene by using Serratia sp.ATCC 39006 genome DNA as a template to obtain upstream homology arm fragments and downstream homology arm fragments, and purifying and recovering the upstream homology arm fragments and the downstream homology arm fragments by using a universal nucleic acid purification and recovery kit;
wherein: the upstream primer D5F and the downstream primer D5R for amplifying the upstream homology arm are respectively:
D5F:5-TGCCTGCAGCTATCGGTTACTCACGCAACATGG-3
D5R:5-TGAGAATTCCTGACTATTTGACAGGTTAAAATCCAT-3
wherein, the upstream primer D3F and the downstream primer D3R for amplifying the downstream homology arm are respectively:
D3F:5-AGGGAATTCGGAACATCATCATGATTATTCAAC-3
D3R:5-GAAGGATCCATATTATCGAGCAACTCCATATGC-3
the PCR amplification system is 25 μ L, and comprises:
10 XDNA polymerase buffer 2.5. mu.L; magnesium ion 1.5 mmol/L; 0.2mmol/L dATP; 0.2mmol/L dTTP; 0.2mmol/L dCTP; 0.2mmol/L dGTP; upstream primer 0.3 mu mol/L; downstream primer 0.3 mu mol/L; 0.1 mu g of template DNA; KOD DNA polymerase 0.5U; the remaining volume was replenished with sterile double distilled water.
The reaction conditions for PCR amplification are as follows:
pre-denaturation at 98 ℃ for 5 min, after the pre-denaturation had ended the following procedure was carried out: denaturation at 98 ℃ for 10 seconds, annealing at 55 ℃ for 30 seconds, and extension at 68 ℃ for 30 seconds, followed by 30 cycles. After the circulation was completed, the temperature was 68 ℃ for 10 minutes.
Using restriction endonucleases PstI and EcoRI to enzyme-cut the upstream homologous arm fragment, purifying and recovering an enzyme-cut product, using restriction endonucleases EcoRI and BamHI to enzyme-cut the downstream homologous arm fragment, purifying and recovering an enzyme-cut product, and obtaining an enzyme-cut upstream homologous arm fragment and an enzyme-cut downstream homologous arm fragment;
connecting the enzyme-cut upstream homologous arm fragment and the enzyme-cut downstream homologous arm fragment with the enzyme-cut pMMB1 plasmid to obtain a connection product of a gene knockout vector pMMB 1-DpigA;
adding 20 mu L of the pMMB1-DpigA ligation product into 100 mu L of Escherichia coli S17-1 (lambda pir) competent cells prepared by a calcium chloride method, uniformly mixing, and standing in an ice bath for 30 minutes;
the mixture is thermally shocked in a water bath kettle at 42 ℃ for 90 seconds and then is ice-cooled for 5 minutes again;
adding 900 μ L LB liquid medium to the mixture, rejuvenating on a constant temperature shaker at 37 deg.C and 200rpm for 45 min, spreading on LB plate containing 50 μ g/mL kanamycin, and culturing overnight in 37 deg.C incubator;
selecting recombinant colonies on the culture medium, carrying out PCR amplification on the recombinant colonies by using detection primers UF and DR, detecting an amplification product by using agarose gel electrophoresis, and finally screening to obtain a positive colony containing a successfully-connected pMMB1-DpigA plasmid;
wherein: the sequences of the detection primers UF and DR are as follows:
UF:5-TAACCATGTTACTGGTAACTGGAA-3
DR:5-CACCACAAAGACAGCCATCATCAA-3
the template DNA of PCR is DNA extracted from somatic cells;
the PCR amplification system is 20 μ L, and comprises:
2 XTaq DNA polymerase buffer 10. mu.L; upstream primer 0.3 mu mol/L; downstream primer 0.3 mu mol/L; 0.1 mu g of template DNA; the remaining volume was replenished with sterile double distilled water.
The reaction conditions for PCR amplification are as follows:
pre-denaturation at 94 ℃ for 10 min, after the pre-denaturation was complete the following procedure was carried out: denaturation at 94 ℃ for 30 seconds, annealing at 55 ℃ for 30 seconds, and extension at 72 ℃ for 30 seconds, followed by 30 cycles. After the circulation was completed, the temperature was 72 ℃ for 10 minutes.
The positive colonies containing successfully ligated pMMB1-DpigA plasmid were DNA sequenced to ensure the correctness of the pMMB1-DpigA plasmid sequence. The pMMB1-DpigA plasmid sequence is shown in SEQ ID NO. 2.
Example 3: method for gene knockout by using pMMB1-DpigA plasmid
This example describes a method for knocking out the pigA gene in Serratia sp.ATCC 39006 by using the pMMB1-DpigA plasmid in example 2. The pigA gene codes for a key enzyme in the process of prodigiosin synthesis, so that the Serratia sp.ATCC 39006 can not produce prodigiosin any more after the gene is knocked out. The method comprises the following steps:
inoculating Serratia sp.ATCC 39006 strain in LB liquid culture medium, and culturing at 30 deg.C and 200rpm in constant temperature shaking table overnight;
coli S17-1 (. lamda. pir) containing the above pMMB1-DpigA plasmid was inoculated into LB liquid medium containing 50. mu.g/mL kanamycin. Culturing the liquid culture medium inoculated with the strains in a constant temperature shaking table at 37 ℃ and 220rpm overnight;
centrifuging the culture solution of Escherichia coli S17-1 (. lamda. pir) containing pMMB1-DpigA plasmid in a high speed centrifuge at 12000rpm for 30 seconds, discarding the supernatant, washing the precipitate twice with LB liquid medium to obtain Escherichia coli S17-1 (. lamda. pir) containing pMMB1-DpigA plasmid;
centrifuging the overnight-cultured Serratia sp.ATCC 39006 in a high-speed centrifuge at 12000rpm for 30 seconds to obtain Serratia sp.ATCC 39006 cells;
resuspending the Serratia sp.ATCC 39006 cell and the Escherichia coli S17-1 (. lamda. pir) cell containing pMMB1-DpigA plasmid in a fresh LB liquid medium, dropping the mixed cell solution on an LB plate, and culturing at 30 ℃ for 12 hours;
scraping the lawn from the LB plate and applying sterile 10mM MgSO4The solution was washed 2 times to remove the attached nutrients. The washed cells were sterilized with 10mM MgSO4The solution was resuspended, gradient diluted and plated on M9 plates containing 50. mu.g/mL kanamycin and incubated for 48 hours at 30 ℃ in an incubator;
selecting the recombinant colony on the M9 plate, carrying out PCR amplification on the recombinant colony by using detection primers UF and DR, detecting an amplification product by using agarose gel electrophoresis (shown in figure 2), and finally screening to obtain a positive colony integrating a pMMB1-DpigA plasmid into a genome, namely a pigA gene single-exchange strain;
wherein: the sequences of the detection primers UF and DR are as follows:
UF:5-TAACCATGTTACTGGTAACTGGAA-3
DR:5-CACCACAAAGACAGCCATCATCAA-3
the template DNA of PCR is DNA extracted from somatic cells;
the PCR amplification system is 20 μ L, and comprises:
2 XTaq DNA polymerase buffer 10. mu.L; upstream primer 0.3 mu mol/L; downstream primer 0.3 mu mol/L; 0.1 mu g of template DNA; the remaining volume was replenished with sterile double distilled water.
The reaction conditions for PCR amplification are as follows:
pre-denaturation at 94 ℃ for 10 min, after the pre-denaturation was complete the following procedure was carried out: denaturation at 94 ℃ for 30 seconds, annealing at 55 ℃ for 30 seconds, extension at 72 ℃ for 1.5 minutes, and 30 cycles were repeated. After the circulation is finished, the temperature is 72 ℃ for 10 minutes
After the correct single-crossover strain of the pigA gene is picked, four-zone streaking is carried out on an LB flat plate containing 50 mu g/mL kanamycin, a single colony is separated, the single colony is inoculated in an LB liquid culture medium containing 50 mu g/mL kanamycin and is cultured in a constant-temperature shaking table at 30 ℃ and 200rpm overnight;
taking the culture solution of the single strain of the PigA gene exchange strain as a seed solution, inoculating the seed solution into an LC liquid culture medium according to the inoculation amount of 0.1%, and culturing for 24 hours in a constant temperature shaking table at 30 ℃ and 200 rpm;
diluting and coating the LC liquid culture medium cultured with the single-exchange strain of the pigA gene on an LCS plate, and culturing for 48 hours in a 30 ℃ thermostat;
selecting the recombinant bacterial colony on the LCS plate, carrying out PCR amplification on the recombinant bacterial colony by using detection primers UF and DR, detecting an amplification product by using agarose gel electrophoresis (shown in an attached figure 3), and finally screening to obtain a positive bacterial colony with the PigA gene knocked out, namely a PigA gene deletion strain;
wherein: the sequences of the detection primers UF and DR are as follows:
UF:5-TAACCATGTTACTGGTAACTGGAA-3
DR:5-CACCACAAAGACAGCCATCATCAA-3
the template DNA of PCR is DNA extracted from somatic cells;
the PCR amplification system is 20 μ L, and comprises:
2 XTaq DNA polymerase buffer 10. mu.L; upstream primer 0.3 mu mol/L; downstream primer 0.3 mu mol/L; 0.1 mu g of template DNA; the remaining volume was replenished with sterile double distilled water.
The reaction conditions for PCR amplification are as follows:
pre-denaturation at 94 ℃ for 10 min, after the pre-denaturation was complete the following procedure was carried out: denaturation at 94 ℃ for 30 seconds, annealing at 55 ℃ for 30 seconds, extension at 72 ℃ for 1.5 minutes, and 30 cycles were repeated. After the circulation was completed, the temperature was 72 ℃ for 10 minutes.
The correct strain with the deletion of the pigA gene and the wild-type Serratia sp.ATCC 39006 are streaked on an LB plate in four regions, and cultured overnight in an incubator at 30 ℃ to observe colonies, so that the colonies of the strain with the deletion of the pigA gene are milk white and can not produce prodigiosin any more (figure 4), and the method disclosed by the embodiment can indeed knock out the pigA gene in the Serratia sp.ATCC 39006.
It will be apparent to those skilled in the art that the above description of specific embodiments of the invention is not intended to limit the application of the invention, and that various equivalents and modifications may be made thereto depending on the circumstances. All such substitutions and modifications are intended to be within the scope of the appended claims without departing from the spirit of the invention.
Sequence listing
<110> university of Jiangsu profession
<120> plasmid pMMB1 for enterobacter gene editing and construction method and application thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 5609
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
tgccgcaagc actcagggcg caagggctgc taaaggaagc ggaacacgta gaaagccagt 60
ccgcagaaac ggtgctgacc ccggatgaat gtcagctact gggctatctg gacaagggaa 120
aacgcaagcg caaagagaaa gcaggtagct tgcagtgggc ttacatggcg atagctagac 180
tgggcggttt tatggacagc aagcgaaccg gaattgccag ctggggcgcc ctctggtaag 240
gttgggaagc cctgcaaagt aaactggatg gctttcttgc cgccaaggat ctgatggcgc 300
aggggatcaa gatctgatca agagacagga tgaggatcgt ttcgcatgat tgaacaagat 360
ggattgcacg caggttctcc ggccgcttgg gtggagaggc tattcggcta tgactgggca 420
caacagacaa tcggctgctc tgatgccgcc gtgttccggc tgtcagcgca ggggcgcccg 480
gttctttttg tcaagaccga cctgtccggt gccctgaatg aactccaaga cgaggcagcg 540
cggctatcgt ggctggccac gacgggcgtt ccttgcgcag ctgtgctcga cgttgtcact 600
gaagcgggaa gggactggct gctattgggc gaagtgccgg ggcaggatct cctgtcatct 660
caccttgctc ctgccgagaa agtatccatc atggctgatg caatgcggcg gctgcatacg 720
cttgatccgg ctacctgccc attcgaccac caagcgaaac atcgcatcga gcgagcacgt 780
actcggatgg aagccggtct tgtcgatcag gatgatctgg acgaagagca tcaggggctc 840
gcgccagccg aactgttcgc caggctcaag gcgcggatgc ccgacggcga ggatctcgtc 900
gtgacccatg gcgatgcctg cttgccgaat atcatggtgg aaaatggccg cttttctgga 960
ttcatcgact gtggccggct gggtgtggcg gaccgctatc aggacatagc gttggctacc 1020
cgtgatattg ctgaagagct tggcggcgaa tgggctgacc gcttcctcgt gctttacggt 1080
atcgccgctc ccgattcgca gcgcatcgcc ttctatcgcc ttcttgacga gttcttctga 1140
gcgggactct ggggttcgct agaggatcga tcctttttaa cccatcacat atacctgccg 1200
ttcactatta tttagtgaaa tgagatatta tgatattttc tgaattgtga ttaaaaaggc 1260
aactttatgc ccatgcaaca gaaactataa aaaatacaga gaatgaaaag aaacagatag 1320
attttttagt tctttaggcc cgtagtctgc aaatcctttt atgattttct atcaaacaaa 1380
agaggaaaat agaccagttg caatccaaac gagagtctaa tagaatgagg tcgaaaagta 1440
aatcgcgcgg gtttgttact gataaagcag gcaagaccta aaatgtgtaa agggcaaagt 1500
gtatactttg gcgtcacccc ttacatattt taggtctttt tttattgtgc gtaactaact 1560
tgccatcttc aaacaggagg gctggaagaa gcagaccgct aacacagtac ataaaaaagg 1620
agacatgaac gatgaacatc aaaaagtttg caaaacaagc aacagtatta acctttacta 1680
ccgcactgct ggcaggaggc gcaactcaag cgtttgcgaa agaaacgaac caaaagccat 1740
ataaggaaac atacggcatt tcccatatta cacgccatga tatgctgcaa atccctgaac 1800
agcaaaaaaa tgaaaaatat caagtttctg aatttgattc gtccacaatt aaaaatatct 1860
cttctgcaaa aggcctggac gtttgggaca gctggccatt acaaaacgct gacggcactg 1920
tcgcaaacta tcacggctac cacatcgtct ttgcattagc cggagatcct aaaaatgcgg 1980
atgacacatc gatttacatg ttctatcaaa aagtcggcga aacttctatt gacagctgga 2040
aaaacgctgg ccgcgtcttt aaagacagcg acaaattcga tgcaaatgat tctatcctaa 2100
aagaccaaac acaagaatgg tcaggttcag ccacatttac atctgacgga aaaatccgtt 2160
tattctacac tgatttctcc ggtaaacatt acggcaaaca aacactgaca actgcacaag 2220
ttaacgtatc agcatcagac agctctttga acatcaacgg tgtagaggat tataaatcaa 2280
tctttgacgg tgacggaaaa acgtatcaaa atgtacagca gttcatcgat gaaggcaact 2340
acagctcagg cgacaaccat acgctgagag atcctcacta cgtagaagat aaaggccaca 2400
aatacttagt atttgaagca aacactggaa ctgaagatgg ctaccaaggc gaagaatctt 2460
tatttaacaa agcatactat ggcaaaagca catcattctt ccgtcaagaa agtcaaaaac 2520
ttctgcaaag cgataaaaaa cgcacggctg agttagcaaa cggcgctctc ggtatgattg 2580
agctaaacga tgattacaca ctgaaaaaag tgatgaaacc gctgattgca tctaacacag 2640
taacagatga aattgaacgc gcgaacgtct ttaaaatgaa cggcaaatgg tacctgttca 2700
ctgactcccg cggatcaaaa atgacgattg acggcattac gtctaacgat atttacatgc 2760
ttggttatgt ttctaattct ttaactggcc catacaagcc gctgaacaaa actggccttg 2820
tgttaaaaat ggatcttgat cctaacgatg taacctttac ttactcacac ttcgctgtac 2880
ctcaagcgaa aggaaacaat gtcgtgatta caagctatat gacaaacaga ggattctacg 2940
cagacaaaca atcaacgttt gcgccgagct tcctgctgaa catcaaaggc aagaaaacat 3000
ctgttgtcaa agacagcatc cttgaacaag gacaattaac agttaacaaa taaaaacgca 3060
aaagaaaatg ccgatgggta ccgagcgaaa tgaccgacca agcgacgccc aacctgccat 3120
cacgagattt cgattccacc gccgccttct atgaaaggtt gggcttcgga atcgttttcc 3180
gggacgccct cgcggacgtg ctcatagtcc acgacgcccg tgattttgta gccctggccg 3240
acggccagca ggtaggccga caggctcatg ccggccgccg ccgccttttc ctcaatcgct 3300
cttcgttcgt ctggaaggca gtacaccttg ataggtgggc tgcccttcct ggttggcttg 3360
gtttcatcag ccatccgctt gccctcatct gttacgccgg cggtagccgg ccagcctcgc 3420
agagcaggat tcccgttgag caccgccagg tgcgaataag ggacagtgaa gaaggaacac 3480
ccgctcgcgg gtgggcctac ttcacctatc ctgcccggct gacgccgttg gatacaccaa 3540
ggaaagtcta cacgaaccct ttggcaaaat cctgtatatc gtgcgaaaaa ggatggatat 3600
accgaaaaaa tcgctataat gaccccgaag cagggttatg cagcggaaaa gcgctgcttc 3660
cctgctgttt tgtggaatat ctaccgactg gaaacaggca aatgcaggaa attactgaac 3720
tgaggggaca ggcgagagac gatgccaaag agctcctgaa aatctcgata actcaaaaaa 3780
tacgcccggt agtgatctta tttcattatg gtgaaagttg gaacctctta cgtgccgatc 3840
aacgtctcat tttcgccaaa agttggccca gggcttcccg gtatcaacag ggacaccagg 3900
atttatttat tctgcgaagt gatcttccgt cacaggtatt tattcggcgc aaagtgcgtc 3960
gggtgatgct gccaacttac tgatttagtg tatgatggtg tttttgaggt gctccagtgg 4020
cttctgtttc tatcagctcc tgaaaatctc gataactcaa aaaatacgcc cggtagtgat 4080
cttatttcat tatggtgaaa gttggaacct cttacgtgcc gatcaacgtc tcattttcgc 4140
caaaagttgg cccagggctt cccggtatca acagggacac caggatttat ttattctgcg 4200
aagtgatctt ccgtcacagg tatttattcg gcgcaaagtg cgtcgggtga tgctgccaac 4260
ttactgattt agtgtatgat ggtgtttttg aggtgctcca gtggcttctg tttctatcag 4320
ggctggatga tcctccagcg cggggatctc atgctggagt tcttcgccca ccccaaaagg 4380
atctaggtga agatcctttt tgataatctc atgaccaaaa tcccttaacg tgagttttcg 4440
ttccactgag cgtcagaccc cgtagaaaag atcaaaggat cttcttgaga ctcgagtctg 4500
aagatcagca gttcaacctg ttgatagtac gtactaagct ctcatgtttc acgtactaag 4560
ctctcatgtt taacgtacta agctctcatg tttaacgaac taaaccctca tggctaacgt 4620
actaagctct catggctaac gtactaagct ctcatgtttc acgtactaag ctctcatgtt 4680
tgaacaataa aattaatata aatcagcaac ttaaatagcc tctaaggttt taagttttat 4740
aagaaaaaaa agaatatata aggcttttaa agcttttaag gtttaacggt tgtggacaac 4800
aagccaggga tgtaacgcac tgagaagccc ttagagcctc tcaaagcaat tttcagtgac 4860
acaggaacac ttaacggctg acatgggaat tctactgttt gggtgtatga gctatttgca 4920
aaggaaattg gtgatgacaa agctctcgag gagcctatgg aaaaacgcca gcaacgcggc 4980
ctttttacgg ttcctggcct tttgctggcc ttttgctcac atgttctttc ctgcgttatc 5040
ccctgattct gtggataacc gtattaccgc ctttgagtga gctgataccg ctcgccgcag 5100
ccgaacgacc gagcgcagcg agtcagtgag cgaggaagcg gaagagcgcc caatacgcaa 5160
accgcctctc cccgcgcgtt ggccgattca ttaatgcagc tggcacgaca ggtttcccga 5220
ctggaaagcg ggcagtgagc gcaacgcaat taatgtgagt tagctcactc attaggcacc 5280
ccaggcttta cactttatgc ttccggctcg tatgttgtgt ggaattgtga gcggataaca 5340
atttcacaca ggaaacagct atgacatgat tacgccaagc ttgcatgcct gcaggtcgac 5400
tctagaggat ccccgggtac cgagctcgaa ttcactggcc gtcgttttac aacgtcgtga 5460
ctgggaaaac cctggcgtta cccaacttaa tcgccttgca gcacatcccc ctttcgccag 5520
ctggcgtaat agcgaagagg cccgcaccga tcgcccttcc caacagttgc gcagcctgaa 5580
tggcgaatgg cgataagcta gcttcacgc 5609
<210> 2
<211> 7658
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
tgccgcaagc actcagggcg caagggctgc taaaggaagc ggaacacgta gaaagccagt 60
ccgcagaaac ggtgctgacc ccggatgaat gtcagctact gggctatctg gacaagggaa 120
aacgcaagcg caaagagaaa gcaggtagct tgcagtgggc ttacatggcg atagctagac 180
tgggcggttt tatggacagc aagcgaaccg gaattgccag ctggggcgcc ctctggtaag 240
gttgggaagc cctgcaaagt aaactggatg gctttcttgc cgccaaggat ctgatggcgc 300
aggggatcaa gatctgatca agagacagga tgaggatcgt ttcgcatgat tgaacaagat 360
ggattgcacg caggttctcc ggccgcttgg gtggagaggc tattcggcta tgactgggca 420
caacagacaa tcggctgctc tgatgccgcc gtgttccggc tgtcagcgca ggggcgcccg 480
gttctttttg tcaagaccga cctgtccggt gccctgaatg aactccaaga cgaggcagcg 540
cggctatcgt ggctggccac gacgggcgtt ccttgcgcag ctgtgctcga cgttgtcact 600
gaagcgggaa gggactggct gctattgggc gaagtgccgg ggcaggatct cctgtcatct 660
caccttgctc ctgccgagaa agtatccatc atggctgatg caatgcggcg gctgcatacg 720
cttgatccgg ctacctgccc attcgaccac caagcgaaac atcgcatcga gcgagcacgt 780
actcggatgg aagccggtct tgtcgatcag gatgatctgg acgaagagca tcaggggctc 840
gcgccagccg aactgttcgc caggctcaag gcgcggatgc ccgacggcga ggatctcgtc 900
gtgacccatg gcgatgcctg cttgccgaat atcatggtgg aaaatggccg cttttctgga 960
ttcatcgact gtggccggct gggtgtggcg gaccgctatc aggacatagc gttggctacc 1020
cgtgatattg ctgaagagct tggcggcgaa tgggctgacc gcttcctcgt gctttacggt 1080
atcgccgctc ccgattcgca gcgcatcgcc ttctatcgcc ttcttgacga gttcttctga 1140
gcgggactct ggggttcgct agaggatcga tcctttttaa cccatcacat atacctgccg 1200
ttcactatta tttagtgaaa tgagatatta tgatattttc tgaattgtga ttaaaaaggc 1260
aactttatgc ccatgcaaca gaaactataa aaaatacaga gaatgaaaag aaacagatag 1320
attttttagt tctttaggcc cgtagtctgc aaatcctttt atgattttct atcaaacaaa 1380
agaggaaaat agaccagttg caatccaaac gagagtctaa tagaatgagg tcgaaaagta 1440
aatcgcgcgg gtttgttact gataaagcag gcaagaccta aaatgtgtaa agggcaaagt 1500
gtatactttg gcgtcacccc ttacatattt taggtctttt tttattgtgc gtaactaact 1560
tgccatcttc aaacaggagg gctggaagaa gcagaccgct aacacagtac ataaaaaagg 1620
agacatgaac gatgaacatc aaaaagtttg caaaacaagc aacagtatta acctttacta 1680
ccgcactgct ggcaggaggc gcaactcaag cgtttgcgaa agaaacgaac caaaagccat 1740
ataaggaaac atacggcatt tcccatatta cacgccatga tatgctgcaa atccctgaac 1800
agcaaaaaaa tgaaaaatat caagtttctg aatttgattc gtccacaatt aaaaatatct 1860
cttctgcaaa aggcctggac gtttgggaca gctggccatt acaaaacgct gacggcactg 1920
tcgcaaacta tcacggctac cacatcgtct ttgcattagc cggagatcct aaaaatgcgg 1980
atgacacatc gatttacatg ttctatcaaa aagtcggcga aacttctatt gacagctgga 2040
aaaacgctgg ccgcgtcttt aaagacagcg acaaattcga tgcaaatgat tctatcctaa 2100
aagaccaaac acaagaatgg tcaggttcag ccacatttac atctgacgga aaaatccgtt 2160
tattctacac tgatttctcc ggtaaacatt acggcaaaca aacactgaca actgcacaag 2220
ttaacgtatc agcatcagac agctctttga acatcaacgg tgtagaggat tataaatcaa 2280
tctttgacgg tgacggaaaa acgtatcaaa atgtacagca gttcatcgat gaaggcaact 2340
acagctcagg cgacaaccat acgctgagag atcctcacta cgtagaagat aaaggccaca 2400
aatacttagt atttgaagca aacactggaa ctgaagatgg ctaccaaggc gaagaatctt 2460
tatttaacaa agcatactat ggcaaaagca catcattctt ccgtcaagaa agtcaaaaac 2520
ttctgcaaag cgataaaaaa cgcacggctg agttagcaaa cggcgctctc ggtatgattg 2580
agctaaacga tgattacaca ctgaaaaaag tgatgaaacc gctgattgca tctaacacag 2640
taacagatga aattgaacgc gcgaacgtct ttaaaatgaa cggcaaatgg tacctgttca 2700
ctgactcccg cggatcaaaa atgacgattg acggcattac gtctaacgat atttacatgc 2760
ttggttatgt ttctaattct ttaactggcc catacaagcc gctgaacaaa actggccttg 2820
tgttaaaaat ggatcttgat cctaacgatg taacctttac ttactcacac ttcgctgtac 2880
ctcaagcgaa aggaaacaat gtcgtgatta caagctatat gacaaacaga ggattctacg 2940
cagacaaaca atcaacgttt gcgccgagct tcctgctgaa catcaaaggc aagaaaacat 3000
ctgttgtcaa agacagcatc cttgaacaag gacaattaac agttaacaaa taaaaacgca 3060
aaagaaaatg ccgatgggta ccgagcgaaa tgaccgacca agcgacgccc aacctgccat 3120
cacgagattt cgattccacc gccgccttct atgaaaggtt gggcttcgga atcgttttcc 3180
gggacgccct cgcggacgtg ctcatagtcc acgacgcccg tgattttgta gccctggccg 3240
acggccagca ggtaggccga caggctcatg ccggccgccg ccgccttttc ctcaatcgct 3300
cttcgttcgt ctggaaggca gtacaccttg ataggtgggc tgcccttcct ggttggcttg 3360
gtttcatcag ccatccgctt gccctcatct gttacgccgg cggtagccgg ccagcctcgc 3420
agagcaggat tcccgttgag caccgccagg tgcgaataag ggacagtgaa gaaggaacac 3480
ccgctcgcgg gtgggcctac ttcacctatc ctgcccggct gacgccgttg gatacaccaa 3540
ggaaagtcta cacgaaccct ttggcaaaat cctgtatatc gtgcgaaaaa ggatggatat 3600
accgaaaaaa tcgctataat gaccccgaag cagggttatg cagcggaaaa gcgctgcttc 3660
cctgctgttt tgtggaatat ctaccgactg gaaacaggca aatgcaggaa attactgaac 3720
tgaggggaca ggcgagagac gatgccaaag agctcctgaa aatctcgata actcaaaaaa 3780
tacgcccggt agtgatctta tttcattatg gtgaaagttg gaacctctta cgtgccgatc 3840
aacgtctcat tttcgccaaa agttggccca gggcttcccg gtatcaacag ggacaccagg 3900
atttatttat tctgcgaagt gatcttccgt cacaggtatt tattcggcgc aaagtgcgtc 3960
gggtgatgct gccaacttac tgatttagtg tatgatggtg tttttgaggt gctccagtgg 4020
cttctgtttc tatcagctcc tgaaaatctc gataactcaa aaaatacgcc cggtagtgat 4080
cttatttcat tatggtgaaa gttggaacct cttacgtgcc gatcaacgtc tcattttcgc 4140
caaaagttgg cccagggctt cccggtatca acagggacac caggatttat ttattctgcg 4200
aagtgatctt ccgtcacagg tatttattcg gcgcaaagtg cgtcgggtga tgctgccaac 4260
ttactgattt agtgtatgat ggtgtttttg aggtgctcca gtggcttctg tttctatcag 4320
ggctggatga tcctccagcg cggggatctc atgctggagt tcttcgccca ccccaaaagg 4380
atctaggtga agatcctttt tgataatctc atgaccaaaa tcccttaacg tgagttttcg 4440
ttccactgag cgtcagaccc cgtagaaaag atcaaaggat cttcttgaga ctcgagtctg 4500
aagatcagca gttcaacctg ttgatagtac gtactaagct ctcatgtttc acgtactaag 4560
ctctcatgtt taacgtacta agctctcatg tttaacgaac taaaccctca tggctaacgt 4620
actaagctct catggctaac gtactaagct ctcatgtttc acgtactaag ctctcatgtt 4680
tgaacaataa aattaatata aatcagcaac ttaaatagcc tctaaggttt taagttttat 4740
aagaaaaaaa agaatatata aggcttttaa agcttttaag gtttaacggt tgtggacaac 4800
aagccaggga tgtaacgcac tgagaagccc ttagagcctc tcaaagcaat tttcagtgac 4860
acaggaacac ttaacggctg acatgggaat tctactgttt gggtgtatga gctatttgca 4920
aaggaaattg gtgatgacaa agctctcgag gagcctatgg aaaaacgcca gcaacgcggc 4980
ctttttacgg ttcctggcct tttgctggcc ttttgctcac atgttctttc ctgcgttatc 5040
ccctgattct gtggataacc gtattaccgc ctttgagtga gctgataccg ctcgccgcag 5100
ccgaacgacc gagcgcagcg agtcagtgag cgaggaagcg gaagagcgcc caatacgcaa 5160
accgcctctc cccgcgcgtt ggccgattca ttaatgcagc tggcacgaca ggtttcccga 5220
ctggaaagcg ggcagtgagc gcaacgcaat taatgtgagt tagctcactc attaggcacc 5280
ccaggcttta cactttatgc ttccggctcg tatgttgtgt ggaattgtga gcggataaca 5340
atttcacaca ggaaacagct atgacatgat tacgccaagc ttgcatgcct gcagctatcg 5400
gttactcacg caacatggct tccgcgcccg gaatttgtcc gggggatata aaacttacag 5460
cctgacgttg tccgcctgaa ccattagcgt tcggattaat cattggcatg atggcaagta 5520
taggggccgt catgccaaac cagatgatgt aatataaaaa tacgatttca ctatgtgagt 5580
gcaataaccg gtatcctttc gcttgccgcc atcttgcaaa taaagttatc caggacatct 5640
atattcatta ttatgtaata tgcttattta ttcaatcttt cgagcattga gtaattactc 5700
ttgtgtcaat attgtatttt attattagat gaggttattt attttattgt tctaacttcg 5760
gaatttattg aactataagt ttaatgatat tgtaatattt aaataatata tggcagtaag 5820
gttttgtata aaacacaata ttaattcaac tgatcagtta accctttatt caggaaaaaa 5880
ctcacgcata ggaacaccat aatctataaa tttatatcat gatatggtca cggtttgcct 5940
cgatacacca attcttcttc accaaattgt aacaataagc ttaatgaatc cctagctgat 6000
gaccttcggt catcagtgtc gttttagcgt cggtttaaca atggcctcta tttacttgca 6060
ataaaaatac ttagctaaat caatattaaa agtgcatcaa tattctcact gctccgtaag 6120
tcagaacaac gtcaaacgct tatgcaagat ctggattgtt taatgtttgt ttattaaaag 6180
tgtaatttgt aaaatattgt gtattgttgt tttattaaaa atttattata tatcaaaggt 6240
taaaccatgt gttaattgtg ggtatgtaac catgttactg gtaactggaa agctattcac 6300
attacgacgt attttccaat gttgcatttt gtgctcatca acattaaaga taatagcgaa 6360
gtcaattaac cgttgtagca atggaagcaa tggagtgttt tatggatttt aacctgtcaa 6420
atagtcagga attcggaaca tcatcatgat tattcaacgg ctcttcggca tcctctatat 6480
gcttgccggt ttggcgaaag ctttcccgca gtttgagaat gttcccgctg ttcttcggca 6540
ggcggcaatt gccaaccagg gaacctggta cgcggcggcg agtatctggc tgggcgcaca 6600
tggtgatgtg atcaatatcc tggtgggagt ggtgctgttt gggtcgggag tgatattaat 6660
gctcaaccca ctctggacga cgctggtgat ctacgcccag cttttgatga tggctgtctt 6720
tgtggtgatt ttgcatcagt cccagcccca ggtcatgttg ctggatggcg tatttgcgct 6780
ggccgcgctt tacatgctgc gcggtcagta tcaccgtaag cctaagccga gaaccttccc 6840
gaccacgtct ttttcgctgc ccacaccctc ttctgaatca tcgttttctg ctcccttggg 6900
tgatgagtat gatgtcgtga ttatcggcgg tggtgcctcc ggactgacgg cggccagtga 6960
atttactcat gaacgggtgt tggtgcttga aaaaagctcc actttcgggg ggaatgcccg 7020
ctaccacacc tttaaccggt taaagcatcc caccgccggt gtttgttttc aagaaccgtt 7080
tcccggttcg aatatgctgc gcttactgaa aaagattggt ctggagggaa aatacaagtc 7140
caacgaaaag gacacgctgg tcttttttga taccttttta ttgctcaaat gcttaggtga 7200
aattgtggtc ggctttatta agcaaccacg ttatctgctc aaactctcgg tctgggggct 7260
gaccagccag ctttttctgc atgcgataat tggtaaaccc tacgtggtag cggccaaaca 7320
acttggtgac ccgatctttg ccgatcttta tacctttctg gataagttct ctcctcgtgg 7380
cgacttttat ccacgcctgc cctggacacc gaacggttcc tggagcaaag cgcatatgga 7440
gttgctcgat aatatggatc cccgggtacc gagctcgaat tcactggccg tcgttttaca 7500
acgtcgtgac tgggaaaacc ctggcgttac ccaacttaat cgccttgcag cacatccccc 7560
tttcgccagc tggcgtaata gcgaagaggc ccgcaccgat cgcccttccc aacagttgcg 7620
cagcctgaat ggcgaatggc gataagctag cttcacgc 7658
Claims (6)
1. A plasmid pMMB1 has a nucleotide sequence shown in SEQ ID NO. 1.
2. A plasmid, pMMB1, characterized by: the nucleotide sequence of the gene is a kanamycin resistance gene and a promoter region thereof from the 208-1140-site deoxyribonucleotide at the 5' end; the 1192-position 3053 deoxyribonucleotide is a fructan sucrase gene sacB and a promoter region thereof; 3407-3516 shows that the deoxyribonucleotide is an IncP group plasmid conjugation transfer site; the 4497-4944 deoxyribonucleotide is a lambda pir protein-dependent replicon oriR 6K; 5287-5586-position deoxyribonucleotide is lacZ alpha gene for screening blue white spots and a promoter region thereof; the 5383-5417-site deoxyribonucleotide is a multiple cloning site for inserting an exogenous fragment.
3. The method of construction of plasmid pMMB1 of claim 1 or 2, characterized in that: the method comprises the following steps:
(1) preparation of the cleavage product of the lambda pir protein-dependent replicon oriR 6K:
(1.1) carrying out PCR amplification on the lambda pir protein-dependent replicon oriR6K by using the plasmid pKNG101 as a template to obtain an amplification product; recovering the amplification product using a universal nucleic acid recovery kit to obtain a lambda pir protein-dependent replicon oriR 6K;
(1.2) treating the recovered amplification product with restriction endonuclease XhoI to obtain a lambda pir protein-dependent replicon oriR6K enzyme-cleaved product, and recovering the product by using a general-purpose nucleic acid recovery kit;
(2) preparation of plasmid backbone digestion product:
(2.1) PCR-amplifying sequences except the replicon by using an upstream primer DoriF and a downstream primer DoriR with the plasmid pK19mobsacB as a template to obtain an amplification product. Recovering the amplification product by using a universal nucleic acid recovery kit to obtain a plasmid skeleton;
(2.2) treating the recovered amplification product with restriction endonuclease XhoI to obtain a plasmid backbone enzyme digestion product, and recovering the enzyme digestion product by using a universal nucleic acid recovery kit;
(3) preparation of plasmid pMMB 1:
and connecting the lambda pir protein dependent replicon oriR6K enzyme digestion product with the plasmid skeleton enzyme digestion product to obtain the pMMB1 plasmid.
4. The method of construction of plasmid pMMB1 of claim 3, wherein: in the step (1.1), the amplification primers in the PCR amplification system are as follows:
the upstream primer R6 KF: 5-CCGCTCGAGTCTGAAGATCAGCAGTTCAACCTG-3;
the downstream primer R6 KR: 5-CCGCTCGAGAGCTTTGTCATCACCAATTTCCTT-3;
the PCR amplification system is 25 μ L, and comprises:
10 XDNA polymerase buffer 2.5. mu.L; 0.2mmol/L dATP; 0.2mmol/L dTTP; 0.2mmol/L dCTP; 0.2mmol/L dGTP; the upstream primer R6KF 0.3 is 0.3 mu mol/L; the downstream primer R6KR 0.3 is 0.3 mu mol/L; 0.1 mu g of template DNA; KOD DNA polymerase 0.5U, magnesium ion 1.5mmol/L, make up the remaining volume with sterilized double distilled water;
the reaction conditions for PCR amplification are as follows:
pre-denaturation at 98 ℃ for 5 min, after the pre-denaturation had ended the following procedure was carried out: denaturation at 98 ℃ for 10 seconds, annealing at 55 ℃ for 30 seconds, extension at 68 ℃ for 20 seconds, repeating for 30 cycles; after the circulation was completed, the temperature was 68 ℃ for 10 minutes.
5. The method of construction of plasmid pMMB1 of claim 3, wherein: in the step (2.1), the amplification primers in the PCR amplification system are as follows:
DoriF:5-CCGCTCGAGGAGCCTATGGAAAAACGCCAGCAACGCGGC-3;
DoriR:5-CCGCTCGAGTCTCAAGAAGATCCTTTGATCTTTTCTACG-3;
the PCR amplification system is 25 μ L, and comprises:
10 XDNA polymerase buffer 2.5. mu.L; 0.2mmol/L dATP; 0.2mmol/L dTTP; 0.2mmol/L dCTP; 0.2mmol/L dGTP; upstream primer DoriF 0.3 mu mol/L; downstream primer DoriR 0.3 mu mol/L; 0.1 mu g of template DNA; KOD DNA polymerase 0.5U, magnesium ion 1.5mmol/L, make up the remaining volume with sterilized double distilled water;
the reaction conditions for PCR amplification are as follows:
pre-denaturation at 98 ℃ for 5 min, after the pre-denaturation had ended the following procedure was carried out: denaturation at 98 ℃ for 10 seconds, annealing at 55 ℃ for 30 seconds, extension at 68 ℃ for 3 minutes, and 30 cycles were repeated. After the circulation was completed, the temperature was 68 ℃ for 10 minutes.
6. Use of the plasmid pMMB1 of claim 1 or 2 for gene editing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011189157.5A CN112359055A (en) | 2020-10-30 | 2020-10-30 | Plasmid pMMB1 for enterobacter gene editing and construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011189157.5A CN112359055A (en) | 2020-10-30 | 2020-10-30 | Plasmid pMMB1 for enterobacter gene editing and construction method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112359055A true CN112359055A (en) | 2021-02-12 |
Family
ID=74513053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011189157.5A Pending CN112359055A (en) | 2020-10-30 | 2020-10-30 | Plasmid pMMB1 for enterobacter gene editing and construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112359055A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101979596A (en) * | 2010-02-03 | 2011-02-23 | 中国农业大学 | Method for constructing recombinant expression vector simultaneously expressing a plurality of genes |
-
2020
- 2020-10-30 CN CN202011189157.5A patent/CN112359055A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101979596A (en) * | 2010-02-03 | 2011-02-23 | 中国农业大学 | Method for constructing recombinant expression vector simultaneously expressing a plurality of genes |
Non-Patent Citations (2)
Title |
---|
OKAMOTO, S.等: "GenBank: LC257601.1", 《GENBANK》 * |
王钰: "多元醇的微生物合成与代谢研究", 《HTTPS://WWW.GS.SJTU.EDU.CN/INFO/1208/5262.HTM?IVK_SA=1024320U》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2260055C2 (en) | Method for dna amplification and composition therefor | |
US6022716A (en) | High throughput DNA sequencing vector | |
EP1396540B1 (en) | Direct cloning of PCR amplified nucleic acids | |
Parker et al. | A relaxed mutant with an altered ribosomal protein L11 | |
US8921072B2 (en) | Methods to generate DNA mini-circles | |
KR20110107846A (en) | Production of closed linear dna | |
CN103080337A (en) | Production of closed linear DNA using a palindromic sequence | |
CN112111469B (en) | Gamma-glutamyl kinase mutant and application thereof | |
WO2010030776A1 (en) | Homologous recombination-based dna cloning methods and compositions | |
JP2003510052A (en) | Methods and compositions for improved polynucleotide synthesis | |
CN112980891B (en) | Coli genome editing tool based on CRISPR-Cas | |
CN112359055A (en) | Plasmid pMMB1 for enterobacter gene editing and construction method and application thereof | |
JP2011505147A (en) | lac expression system | |
CN115896063A (en) | High-fidelity Pfu DNA polymerase mutant, preparation method and application thereof | |
CN116064462A (en) | Taq DNA polymerase mutant and preparation method thereof | |
Reece-Hoyes et al. | Using multisite LR cloning to generate a Destination clone | |
KR102282778B1 (en) | Recombinant microorganisms and methods of use thereof | |
CN113652424A (en) | Promoter for improving glutamine transaminase expression level | |
CN108866091B (en) | Plasmid for improving squalene content of rhodopseudomonas palustris and preparation and use methods thereof | |
CN110863004A (en) | Yeast two-hybrid vector, construction method and application thereof in protein interaction | |
Tirgari et al. | Genetics of NAD metabolism in Salmonella typhimurium and cloning of the nadA and pnuC loci | |
CN1700925A (en) | Plasmid-free clone of E. coli strain DSM 6601 | |
CN116144630B (en) | Double-strand specific nuclease mutant and application thereof | |
CN113943747B (en) | Burkholderia for producing bihydrogen Jianlan nystatin and preparation method thereof | |
KR101155368B1 (en) | Nanoarchaeum equitans plus DNA polymerase, method for preparing the same and its PCR method using dUTP and uracil-DNA glycosylase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210212 |